Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain
Conditions
- Moderate to Severe Chronic, Non-malignant Pain
Interventions
- DRUG: Hydrocodone/Acetaminophen on Extended Release
Sponsor
Abbott